Large Scale Molecular Studies of Pituitary Neuroendocrine Tumors: Novel Markers, Mechanisms and Translational Perspectives
- PMID: 33808624
- PMCID: PMC8003417
- DOI: 10.3390/cancers13061395
Large Scale Molecular Studies of Pituitary Neuroendocrine Tumors: Novel Markers, Mechanisms and Translational Perspectives
Abstract
Pituitary neuroendocrine tumors (PitNETs) are non-metastatic neoplasms of the pituitary, which overproduce hormones leading to systemic disorders, or tumor mass effects causing headaches, vertigo or visual impairment. Recently, PitNETs have been investigated in large scale (exome and genome) molecular analyses (transcriptome microarrays and sequencing), to uncover novel markers. We performed a literature analysis on these studies to summarize the research data and extrapolate overlapping gene candidates, biomarkers, and molecular mechanisms. We observed a tendency in samples with driver mutations (GNAS, USP8) to have a smaller overall mutational rate, suggesting driver-promoted tumorigenesis, potentially changing transcriptome profiles in tumors. However, direct links from drivers to signaling pathways altered in PitNETs (Notch, Wnt, TGF-β, and cell cycle regulators) require further investigation. Modern technologies have also identified circulating nucleic acids, and pinpointed these as novel PitNET markers, i.e., miR-143-3p, miR-16-5p, miR-145-5p, and let-7g-5p, therefore these molecules must be investigated in the future translational studies. Overall, large-scale molecular studies have provided key insight into the molecular mechanisms behind PitNET pathogenesis, highlighting previously reported molecular markers, bringing new candidates into the research field, and reapplying traditional perspectives to newly discovered molecular mechanisms.
Keywords: large scale molecular analysis; molecular markers; pituitary neuroendocrine tumors.
Conflict of interest statement
The authors declare no conflict of interest.
Figures

Similar articles
-
Genome wide analysis of circulating miRNAs in growth hormone secreting pituitary neuroendocrine tumor patients' plasma.Front Oncol. 2022 Sep 9;12:894317. doi: 10.3389/fonc.2022.894317. eCollection 2022. Front Oncol. 2022. PMID: 36158656 Free PMC article.
-
Whole exome sequencing reveals novel risk genes of pituitary neuroendocrine tumors.PLoS One. 2022 Aug 26;17(8):e0265306. doi: 10.1371/journal.pone.0265306. eCollection 2022. PLoS One. 2022. PMID: 36026497 Free PMC article.
-
Quantitative Acetylomics Revealed Acetylation-Mediated Molecular Pathway Network Changes in Human Nonfunctional Pituitary Neuroendocrine Tumors.Front Endocrinol (Lausanne). 2021 Oct 12;12:753606. doi: 10.3389/fendo.2021.753606. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34712204 Free PMC article.
-
Pituitary Tumors: Genetic and Molecular Factors Underlying Pathogenesis and Clinical Behavior.Neuroendocrinology. 2022;112(1):15-33. doi: 10.1159/000514862. Epub 2021 Feb 1. Neuroendocrinology. 2022. PMID: 33524974 Review.
-
Muti-omics integration analysis revealed molecular network alterations in human nonfunctional pituitary neuroendocrine tumors in the framework of 3P medicine.EPMA J. 2022 Feb 17;13(1):9-37. doi: 10.1007/s13167-022-00274-5. eCollection 2022 Mar. EPMA J. 2022. PMID: 35273657 Free PMC article. Review.
Cited by
-
Importance of early detection in multiple endocrine neoplasia type 1: Clinical insights and future directions.World J Gastrointest Oncol. 2025 Apr 15;17(4):100013. doi: 10.4251/wjgo.v17.i4.100013. World J Gastrointest Oncol. 2025. PMID: 40235881 Free PMC article.
-
Proteogenomic landscape and clinical characterization of GH-producing pituitary adenomas/somatotroph pituitary neuroendocrine tumors.Commun Biol. 2022 Nov 27;5(1):1304. doi: 10.1038/s42003-022-04272-1. Commun Biol. 2022. PMID: 36435867 Free PMC article.
-
4-Nitrophenol-Loaded Magnetic Mesoporous Silica Hybrid Materials for Spectrometric Aptasensing of Carcinoembryonic Antigen.Micromachines (Basel). 2021 Sep 22;12(10):1138. doi: 10.3390/mi12101138. Micromachines (Basel). 2021. PMID: 34683189 Free PMC article.
-
Molecular Markers of Telomerase Complex for Patients with Pituitary Adenoma.Brain Sci. 2022 Jul 25;12(8):980. doi: 10.3390/brainsci12080980. Brain Sci. 2022. PMID: 35892421 Free PMC article.
-
Clinical Biology of the Pituitary Adenoma.Endocr Rev. 2022 Nov 25;43(6):1003-1037. doi: 10.1210/endrev/bnac010. Endocr Rev. 2022. PMID: 35395078 Free PMC article. Review.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous